Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life

Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life

In a previous study, 3-dose primary vaccination of Nigerian infants with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) was immunogenic for vaccine pneumococcal serotypes, with comparable tolerability between PHiD-CV and control groups. In an open...

Full description

Bibliographic Details
Main Authors: Odusanya, Olumuyiwa O, Kuyinu, Yetunde A, Kehinde, Omolara A, Shafi, Fakrudeen, François, Nancy, Yarzabal, Juan Pablo, Dobbelaere, Kurt, Rüggeberg, Jens U, Borys, Dorota, Schuerman, Lode
Format: Online
Language:English
Published: Landes Bioscience 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130271/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130271/

Similar Items